Literature DB >> 1300103

Artificial liver support based on artificial cells with emphasis on encapsulated hepatocytes.

T M Chang1.   

Abstract

Artificial liver support requires more than a detoxification system. We have investigated additional approaches. Microencapsulated hepatocytes increased the survival time of fulminant hepatic failure (FHF) rats. They also lowered the bilirubin in Gunn rats. Xenograft of microencapsulated rat hepatocytes into mice are immunoisolated. The viability of hepatocyte increased from 62 to 100% after 29 days. This is because of accumulation of a hepatic stimulatory factor (> 100,000 D) secreted by the hepatocytes in the artificial cells. A novel two-step method of cell encapsulation greatly improved immunoisolation and biocompatibility. Other metabolic approaches included a multienzyme system for conversion of ammonia to essential amino acid, and removal of bilirubin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1300103     DOI: 10.1111/j.1525-1594.1992.tb00270.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  2 in total

Review 1.  Macroscale delivery systems for molecular and cellular payloads.

Authors:  Cathal J Kearney; David J Mooney
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

2.  Celiac disease and lymphoma risk: a multicentric case--control study in Spain.

Authors:  Carme Farré; Eva Domingo-Domenech; Rebeca Font; Teresa Marques; Alberto Fernandez de Sevilla; Tomas Alvaro; Mercedes Garcia Villanueva; Vicens Romagosa; Silvia de Sanjose
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.